1. Home
  2. DSX vs MYGN Comparison

DSX vs MYGN Comparison

Compare DSX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.53

Market Cap

357.1M

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.13

Market Cap

372.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
MYGN
Founded
1999
1991
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.1M
372.1M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
DSX
MYGN
Price
$2.53
$4.13
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
★ $4.11
AVG Volume (30 Days)
998.3K
★ 1.6M
Earning Date
11-19-2026
11-04-2026
Dividend Yield
★ 1.60%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $771,400,000.00
Revenue This Year
$13.33
N/A
Revenue Next Year
$8.68
$5.47
P/E Ratio
$16.02
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$1.60
$2.74
52 Week High
$3.20
$8.50

Technical Indicators

Market Signals
Indicator
DSX
MYGN
Relative Strength Index (RSI) 32.73 51.29
Support Level $2.27 $2.89
Resistance Level $2.61 $4.89
Average True Range (ATR) 0.10 0.26
MACD -0.05 -0.04
Stochastic Oscillator 9.57 19.41

Price Performance

Historical Comparison
DSX
MYGN

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: